Published in J Neuroimmunol on April 01, 1983
Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol (1986) 3.31
T-cell-mediated clearance of mouse hepatitis virus strain JHM from the central nervous system. J Virol (1989) 1.27
Vaccination against persistent viral infection exacerbates CD4+ T-cell-mediated immunopathological disease. J Virol (1997) 1.08
Analysis of antibody responses to predominant linear epitopes of Theiler's murine encephalomyelitis virus. J Virol (1994) 1.04
Gamma interferon signaling in macrophage lineage cells regulates central nervous system inflammation and chemokine production. J Virol (2009) 0.96
Apolipoprotein E does not cross the blood-cerebrospinal fluid barrier, as revealed by an improved technique for sampling CSF from mice. Am J Physiol Regul Integr Comp Physiol (2012) 0.87
Circulating brain microvascular endothelial cells (cBMECs) as potential biomarkers of the blood-brain barrier disorders caused by microbial and non-microbial factors. PLoS One (2013) 0.87
Meningitic Escherichia coli K1 penetration and neutrophil transmigration across the blood-brain barrier are modulated by alpha7 nicotinic receptor. PLoS One (2011) 0.85
Spread of herpes simplex virus to the cerebrospinal fluid and the meninges in experimental mouse encephalitis. Acta Neuropathol (1992) 0.83
Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells. Nat Commun (2016) 0.81
Cyclic ADP-Ribose and Heat Regulate Oxytocin Release via CD38 and TRPM2 in the Hypothalamus during Social or Psychological Stress in Mice. Front Neurosci (2016) 0.79
Androgens suppress antigen-specific T cell responses and IFN-γ production during intracranial LCMV infection. J Neuroimmunol (2010) 0.78
Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell (1993) 4.59
RNA of mouse hepatitis virus. J Virol (1978) 4.27
Mouse hepatitis virus A59: mRNA structure and genetic localization of the sequence divergence from hepatotropic strain MHV-3. J Virol (1981) 4.00
Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus. Proc Natl Acad Sci U S A (1984) 3.81
Pathogenesis of demyelination induced by a mouse hepatitis. Arch Neurol (1973) 3.50
Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol (1986) 3.31
Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy. N Engl J Med (1972) 3.09
Presence of leader sequences in the mRNA of mouse hepatitis virus. J Virol (1983) 3.06
High-frequency RNA recombination of murine coronaviruses. J Virol (1986) 2.91
Replication of mouse hepatitis virus: negative-stranded RNA and replicative form RNA are of genome length. J Virol (1982) 2.86
Characterization of replicative intermediate RNA of mouse hepatitis virus: presence of leader RNA sequences on nascent chains. J Virol (1983) 2.80
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology (2009) 2.58
Characterization of two RNA polymerase activities induced by mouse hepatitis virus. J Virol (1982) 2.46
Further characterization of mRNA's of mouse hepatitis virus: presence of common 5'-end nucleotides. J Virol (1982) 2.34
Comparative analysis of RNA genomes of mouse hepatitis viruses. J Virol (1981) 2.30
Recombination between nonsegmented RNA genomes of murine coronaviruses. J Virol (1985) 2.21
Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system. J Immunol (1999) 2.19
The 5'-end sequence of the murine coronavirus genome: implications for multiple fusion sites in leader-primed transcription. Virology (1987) 2.17
Leader sequences of murine coronavirus mRNAs can be freely reassorted: evidence for the role of free leader RNA in transcription. Proc Natl Acad Sci U S A (1986) 2.16
Antigenic relationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus. Virology (1983) 2.11
Phosphoproteins of murine hepatitis viruses. J Virol (1979) 2.07
Characterization of leader-related small RNAs in coronavirus-infected cells: further evidence for leader-primed mechanism of transcription. Virus Res (1985) 2.07
Interactions between coronavirus nucleocapsid protein and viral RNAs: implications for viral transcription. J Virol (1988) 2.00
IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J Immunol (1999) 2.00
Host cell nuclear function and murine hepatitis virus replication. J Gen Virol (1981) 2.00
The olivopontocerebellar atrophies: a review. Medicine (Baltimore) (1970) 1.98
Etiology of progressive multifocal leukoencephalopathy. Identification of papovavirus. N Engl J Med (1973) 1.90
Viral infections and demyelinating diseases. N Engl J Med (1973) 1.84
Establishing a genetic recombination map for murine coronavirus strain A59 complementation groups. Virology (1990) 1.79
The nucleic acid of an SV40-like virus isolated from a patient with progressive multifocal leukoencephalopathy. Virology (1973) 1.71
Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells. J Virol (1990) 1.70
Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology (1989) 1.66
Further characterization of mouse hepatitis virus RNA-dependent RNA polymerases. Virology (1984) 1.64
Murine coronaviruses: isolation and characterization of two plaque morphology variants of the JHM neurotropic strain. J Gen Virol (1982) 1.62
Chronic central nervous system demyelination in mice after JHM virus infection. Neurology (1981) 1.57
Pathogenesis of mouse hepatitis virus-induced demyelination. J Neurovirol (1996) 1.57
Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated. J Neuroimmunol (1990) 1.57
Mouse hepatitis virus is cleared from the central nervous systems of mice lacking perforin-mediated cytolysis. J Virol (1997) 1.54
Analysis of intracellular small RNAs of mouse hepatitis virus: evidence for discontinuous transcription. Virology (1987) 1.52
Coronavirus translational regulation: leader affects mRNA efficiency. Virology (1994) 1.50
Dissociation of demyelination and viral clearance in congenitally immunodeficient mice infected with murine coronavirus JHM. J Neurovirol (1996) 1.46
Cerebral plasmacytoma with myeloma protein in the cerebrospinal fluid. Neurology (1966) 1.46
Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease. J Immunol (1995) 1.46
Papovavirus of JC type in progressive multifocal leukoencephalopathy. Rapid identification and subsequent isolation. Arch Neurol (1973) 1.43
Coronaviridae. Intervirology (1983) 1.42
Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology (2000) 1.42
Mutational analysis of the transferrin receptor reveals overlapping HFE and transferrin binding sites. J Mol Biol (2001) 1.41
Mouse hepatitis virus-induced recurrent demyelination. A preliminary report. Arch Neurol (1975) 1.39
Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol (1997) 1.39
Neuropathogenicity of mouse hepatitis virus JHM isolates differing in hemagglutinin-esterase protein expression. J Neurovirol (1995) 1.37
Experimental encephalitis following peripheral inoculation of West Nile virus in mice of different ages. J Hyg (Lond) (1970) 1.34
Virions from progressive multifocal leukoencephalopathy: rapid serological identification by electron microscopy. Science (1972) 1.33
In vivo RNA-RNA recombination of coronavirus in mouse brain. J Virol (1988) 1.33
Dengue virus-induced modifications of host cell membranes. J Virol (1975) 1.33
Multiple recombination sites at the 5'-end of murine coronavirus RNA. Virology (1987) 1.32
Impaired T cell immunity in B cell-deficient mice following viral central nervous system infection. J Immunol (2001) 1.31
Multiple sclerosis: measurement and validation of central nervous system IgG synthesis rate. Neurology (1980) 1.29
Sequential infection of glial cells by the murine hepatitis virus JHM strain (MHV-4) leads to a characteristic distribution of demyelination. Lab Invest (1992) 1.29
Further studies of a simian virus 40-like virus isolated from human brain. J Virol (1972) 1.28
The role of IL-10 in mouse hepatitis virus-induced demyelinating encephalomyelitis. Virology (1998) 1.28
Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis. J Exp Med (1999) 1.27
T-cell-mediated clearance of mouse hepatitis virus strain JHM from the central nervous system. J Virol (1989) 1.27
Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis. J Immunol (2001) 1.26
The defect in delayed-type hypersensitivity of young adult SJL mice is due to a lack of functional antigen-presenting cells. Eur J Immunol (1985) 1.25
High affinity interaction between nucleocapsid protein and leader/intergenic sequence of mouse hepatitis virus RNA. J Gen Virol (2000) 1.24
The JHM strain of mouse hepatitis virus induces a spike protein-specific Db-restricted cytotoxic T cell response. J Gen Virol (1996) 1.24
MHV infection of the CNS: mechanisms of immune-mediated control. Viral Immunol (2001) 1.23
Role of viral persistence in retaining CD8(+) T cells within the central nervous system. J Virol (2000) 1.21
RNA recombination of murine coronaviruses: recombination between fusion-positive mouse hepatitis virus A59 and fusion-negative mouse hepatitis virus 2. J Virol (1988) 1.19
Regeneration of oligodendroglia during recovery from demyelinating disease. Science (1977) 1.18
Comparison of six different murine coronavirus JHM variants by monoclonal antibodies against the E2 glycoprotein. Virology (1989) 1.18
Experimental demyelination induced by coronavirus JHM (MHV-4): molecular identification of a viral determinant of paralytic disease. Microb Pathog (1987) 1.18
In vivo effects of coronavirus-specific T cell clones: DTH inducer cells prevent a lethal infection but do not inhibit virus replication. J Immunol (1986) 1.17
Characterization of the structural proteins of the murine coronavirus strain A59 using monoclonal antibodies. Proc Soc Exp Biol Med (1987) 1.16
Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis. J Immunol (1995) 1.16
Coronavirus: a jumping RNA transcription. Cold Spring Harb Symp Quant Biol (1987) 1.15
Evolution of mouse hepatitis virus (MHV) during chronic infection: quasispecies nature of the persisting MHV RNA. Virology (1995) 1.14
Evidence for both respiratory syncytial virus and measles virus antigens in the osteoclasts of patients with Paget's disease of bone. Clin Orthop Relat Res (1984) 1.14
Antibody prevents virus reactivation within the central nervous system. J Immunol (1999) 1.14
A spike protein-dependent cellular factor other than the viral receptor is required for mouse hepatitis virus entry. Virology (1993) 1.14
Synthesis and subcellular localization of the murine coronavirus nucleocapsid protein. Virology (1983) 1.13
Kinetics of cytokine mRNA expression in the central nervous system following lethal and nonlethal coronavirus-induced acute encephalomyelitis. Virology (1997) 1.13